A citation-based method for searching scientific literature

Suresh Rama Chandran, Wei Lin Tay, Weng Kit Lye, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, Daphne S L Gardner. Diabetes Technol Ther 2018
Times Cited: 43



Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
Times Cited: 199




List of shared articles



Times cited

Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data.
Jędrzej Chrzanowski, Arkadiusz Michalak, Aleksandra Łosiewicz, Hanna Kuśmierczyk, Beata Mianowska, Agnieszka Szadkowska, Wojciech Fendler. Diabetes Technol Ther 2021
2


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
604

Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care.
Emma G Wilmot, Pratik Choudhary, Lalantha Leelarathna, Mike Baxter. Diabetes Obes Metab 2019
13

Associations of Time in Range and Other Continuous Glucose Monitoring-Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends.
Dominic Ehrmann, Lilli Priesterroth, Andreas Schmitt, Bernhard Kulzer, Norbert Hermanns. Diabetes Spectr 2021
0

Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel.
Sanjay Kalra, Shehla Shaikh, Gagan Priya, Manas P Baruah, Abhyudaya Verma, Ashok K Das, Mona Shah, Sambit Das, Deepak Khandelwal, Debmalya Sanyal,[...]. Diabetes Ther 2021
1

Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C).
Thomas W Martens, Richard M Bergenstal, Teresa Pearson, Anders L Carlson, Gary Scheiner, Campos Carlos, Birong Liao, Kristen Syring, Roy Daniel Pollom. Postgrad Med 2021
0

Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
Suresh Rama Chandran, Robert A Vigersky, Andreas Thomas, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tan, Daphne S L Gardner. Diabetes Technol Ther 2020
5

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
George Grunberger, Jennifer Sherr, Myriam Allende, Thomas Blevins, Bruce Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, Victor Lawrence Roberts, David Rodbard,[...]. Endocr Pract 2021
2


Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections.
Sara Hallström, Irl B Hirsch, Magnus Ekelund, Sheyda Sofizadeh, Henrik Albrektsson, Solveig Dahlqvist, Ann-Marie Svensson, Marcus Lind. Diabetes Technol Ther 2021
1

Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?
Bruno Vergès, Elise Pignol, Alexia Rouland, Benjamin Bouillet, Sabine Baillot-Rudoni, Emilienne Quilot, Abdelmadjid Djeffal, Jean Michel Petit. J Diabetes Sci Technol 2021
0

THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Simon Helleputte, Tine De Backer, Patrick Calders, Bart Pauwels, Samyah Shadid, Bruno Lapauw. Endocr Pract 2021
1

Diabetes Healthcare Professionals Use Multiple Continuous Glucose Monitoring Data Indicators to Assess Glucose Management.
Tong Sheng, Reid Offringa, David Kerr, Mark Clements, Jerome Fischer, Linda Parks, Michael Greenfield. J Diabetes Sci Technol 2020
1